Cationic liposome-nucleic acid (CL-NA) complexes, which form spontaneously, are a hig modular gene delivery system. These complexes can be sterically stabilized via PEGylation [PE poly(ethylene glycol)] into nanoparticles (NPs) and targeted to specific tissues and cell types via conjugation of an affinity ligand. However, there are currently no guidelines on how to effectiv navigate the large space of compositional parameters that modulate the specific and nonspec binding interactions of peptide-targeted NPs with cells. Such guidelines are desirable to accelerate optimization of formulations with novel peptides. Using PEG-lipids functionalized with a library prototypical tumor-homing peptides, we varied the peptide density and other parameters (binding m peptide charge, CL/DNA charge ratio) to study their effect on the binding and uptake of corresponding NPs. We used flow cytometry to quantitatively assess binding as well as internaliza of NPs by cultured cancer cells. Surprisingly, full peptide coverage resulted in less binding internalization than intermediate coverage, with the optimum coverage varying between cell lines. addition, our data revealed that great care must be taken to prevent nonspecific electrost interactions from interfering with the desired specific binding and internalization. Importantly, s considerations must take into account the charge of the peptide ligand as well as the membrane cha density and the CL/DNA charge ratio. To test our guidelines, we evaluated the in vivo tumor selecti of selected NP formulations in a mouse model of peritoneally disseminated human gastric can Intraperitoneally administered peptide-tagged CL-DNA NPs showed tumor binding, mini accumulation in healthy control tissues, and preferential penetration of smaller tumor nodules, a hig clinically relevant target known to drive recurrence of the peritoneal cancer.
Introduction
Delivery of nucleic acids with nanoscale nonviral carriers to effectively replace, silence, or edit genes for therapeutic purposes is an important but still elusive goal [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Viruses are the conventional choice for gene vectors and account for the majority of ongoing human gene therapy clinical trials [1] .
However, viral vectors suffer from limited loading capacity (due to finite capsid size) and safety concerns: clinical applications of engineered retroviral and adenoviral vectors have resulted in cancer in four patients (due to insertional mutagenesis) and in severe immune reactions resulting in two deaths [11] [12] [13] . Synthetic delivery vectors based on, e.g., lipids or polymers, are widely investigated as a desirable, safer alternative [2] [3] [4] [5] [6] [7] 14] . Lipid-based vectors allow facile tuning of the physicochemical properties relevant for the safe and controlled delivery of nucleic acids. The major challenges for synthetic vectors are improving their transfection efficiency (TE, a measure of the expression of exogenous DNA transferred into the cell by a vector) and tissue and cell specificity in vivo, to match or exceed that of viral vectors [2] [3] [4] [5] [6] [7] .
Cationic liposomes (CLs) spontaneously form condensed CL-nucleic acid (CL-NA) complexes with liquid crystalline phases when mixed with DNA or RNA [3, 15, 16] . Typically, CL-NA complexes are prepared using excess cationic lipid (i.e., at a lipid (positive) to DNA (negative) charge ratio, ρ ch , greater than 1), resulting in complexes with an overall positive charge [16, 17] . This positive charge mediates attractive interactions between the CL-NA complexes and surface proteoglycans, which contain negatively charged sulfate groups [18, 19] . The attractive interactions aid cell binding and subsequent endocytosis and also promote fusion with anionic endosomal membranes, thereby facilitating endosomal escape and release of the NA cargo into the cytoplasm. Different CL-NA nanostructures, created by using lipids with different spontaneous curvatures (dependent on lipid shape) [20, 21] , interact differently with cellular membranes, affecting membrane fusion and TE. Most common is a multilamellar structure (L α C ), with alternating layers of DNA and cationic lipid bilayers ( Figure 1A ) [16, 22] . Another parameter which affects the TE of CL-NA complexes, and is related to electrostatic interactions, is the membrane charge density (σ M ; the average charge per membrane area). The membrane charge density is a predictive parameter for the TE of L α C CL-NA complexes in vitro [18, 23] .
Similar to ρ ch , σ M modulates the surface charge and with it the strength of electrostatic interactions between the membranes of the complex and the cell [16, 24] .
Cationic lipid-based gene delivery in vivo is challenging due to clearance of cationic liposomal carriers by cells of the reticuloendothelial system, resulting in short circulation lifetimes and the lack of selectivity in the binding of carriers towards desired cells and tissue types [25, 26] . The circulation lifetime can be extended by limiting nonspecific protein binding. To achieve this, PEG-lipids [PEG:
poly(ethylene glycol)] can be incorporated into CL-NA complexes, with the polymer chains in the brush state (e.g., 10 mol% for PEG of MW 2000 Da or 5 mol% for PEG of MW 5000 Da). This creates a hydrophilic corona that stabilizes the complexes into nanoparticles (NPs) [17, [27] [28] [29] [30] [31] and limits opsonization and nonspecific protein binding through a combination of steric repulsion and effective charge screening ( Fig. 1A ) [32] [33] [34] [35] [36] . Such a limiting of nonspecific interactions reduces TE but opens up possibilities for specific targeting by attachment of affinity ligands (e.g., peptides, antibodies) that selectively interact with molecules expressed on the target cells or tissue ( Fig. 1 ) [25, 26, 37, 38] . Specifically, surface functionalization of NPs with homing peptides, by incorporation of peptide-PEG-lipids, provides a combination of affinity targeting and steric stabilization for precise guided delivery. Homing peptides are small (and typically straightforward to synthesize, eliminating the need for antibody protein engineering), not strongly immunogenic, and have a moderate affinity that circumvents the affinity site barrier [39, 40] . In addition, homing peptides are particularly suited for the targeting of nanoparticles, where multivalent interactions can significantly enhance target-specific avidity (by up to 4 orders of magnitude) [41] and thus the binding strength of the final material is readily tunable by adjusting the peptide density. Numerous homing peptides have been identified using in vivo phage display [42] [43] [44] , allowing targeting of a variety of disease states and normal tissues [45, 46] . Some homing peptides also confer additional therapeutically valuable properties such as membrane or tissue penetration [47, 48] . the Royal Society of Chemistry. (B) Chemical structure of the peptide-PEG-lipid molecules used in work to provide targeting for CL-NA NPs. A PEG2000-lipid building block was conjugated wit peptide (linear RGD, iRGD, cyclic RGD, or linear RPARPAR). [38] In all cases, PEG MW=2000 g/ (n=44). X: 6-amino-hexanoic acid. See Figure S1 in the Supplementary Material for the chem structures and charge of the peptides.
Proof of principle has been established that specific, peptide-mediated interactions can rest some of the TE that is lost when nonspecific electrostatic interactions are suppressed by PEGyla [31, 38] . However, little is known about how to select compositional parameters for peptide-targeted C DNA NPs to achieve maximum effectiveness in vitro (strong binding to and internalization by tar cells but minimal nonspecific binding and internalization) and how these results transfer to in v studies. To fully explore the relevant parameter space requires testing of a large number of formulations. This is expensive and time-consuming, to the extent of being prohibitive for in vivo evaluation. Thus, it is desirable to identify which parameters, and within what boundaries, need to be explored on a case-by-case basis rather than only once in a model system. Accordingly, the main goal of our study was to identify universal guidelines for the preparation of peptide-targeted nanoparticles that will inform and accelerate the work of optimizing formulations with novel homing peptides. Using a library of peptide-PEG-lipids [38] (Fig. 1B) , we varied the peptide density and the lipid/DNA charge ratio to study the effect of these parameters (peptide type, peptide density, charge ratio) on the in vitro cell binding and internalization of the corresponding nanoparticles as measured by flow cytometry in two human cancer cell lines, PC-3 (prostate cancer) and M-21 (melanoma; lacking neuropilin-1).
As representative peptides, we focused on linear and cyclic peptides with the RGD [49, 50] and Cend rule (CendR, R/KXXR/K) [51] targeting motifs, which bind to integrins and neuropilin-1 (NRP-1), respectively. Both of these receptors are commonly overexpressed in tumor cells, making them popular targets for cancer-homing NPs [52] [53] [54] . The linear RGD peptide, GRGDSP, binds to multiple integrins, with α 5 β 1 integrin being a preferred binding partner [55] . Cyclic RGD peptides, such as the c(RGDfK) used in this work [56, 57] , are conformationally restricted, which enables them to bind more selectively and strongly than linear RGD peptides. Thus, cyclic peptides can selectively target specific integrins. In the case of c(RGDfK), this target is the α v β 3 integrin that is overexpressed in many tumors [53, 54] . RPARPAR, a linear prototypic CendR peptide, interacts with both NRP-1 and NRP-2, triggering cellular internalization, extravasation, and tissue penetration of the peptide and coupled payloads [58, 59] . The cyclic iRGD (c(CRGDKGPDC)) peptide binds to α v integrins for tumor recruitment and is processed by tumor proteases to expose a cryptic CendR motif (RGDK) to trigger NPR-1 binding. This dual binding actuates tumor-specific extravasation and accumulation of iRGD [58, [60] [61] [62] [63] [64] [65] [66] [67] [68] . For example, a recent study found that iRGD-and RPARPAR-conjugated polymersomes loaded with paclitaxel show enhanced targeting and antitumor activity in mouse models of peritoneally-disseminated tumors [48] .
Our results provide insight into the interplay of nonspecific, charge-mediated and specific, peptidemediated interactions and highlight the importance of considering charge, including the charge on the peptide ligand, when designing peptide-targeted CL-NA NPs. Surprisingly, binding and internalization was highest at moderate rather than maximum peptide density.
To validate our in vitro results, we assessed the tumor targeting of selected formulations of CL-NA NPs in vivo. For this, we used a mouse model of human gastric cancer which spreads locoregionally in the peritoneal cavity, forming disseminated tumors (a condition known as peritoneal carcinomatosis, PC) [69] . Previous studies have found that the therapeutic efficacy of IP-administered polymer-and iron oxide-based nanoparticles can be improved by targeting with CendR peptides [48, 70] . In our study, CL-DNA NPs were injected intraperitoneally, and their biodistribution and tumor penetration were assessed using whole-organ imaging and confocal imaging of sectioned tumor tissue, respectively.
Targeted NPs showed very good tumor homing and low accumulation in nonmalignant control tissues.
Untargeted CL-DNA NPs also showed preferential accumulation in tumor tissue, but unlike these control NPs, targeted NPs preferentially bound to and penetrated into smaller tumor nodules, a highly clinically relevant target known to drive recurrence of the cancer after cytoreductive surgery.
Materials and Methods
Materials DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) was purchased from Avanti Polar Lipids as a solution in chloroform. Cholesterol was obtained in powder form from Sigma Life Science. Pentavalent MVL5, PEG2000-lipid, RGD-, iRGD-, cRGD-, and RPARPAR-PEG2000-lipid were synthesized as previously described [38, 71, 72] . The pGFP plasmid encoding the GFP gene was purchased from Promega, propagated in Escherichia coli, and purified using Qiagen Giga or Mega Prep kits. Stock solutions of pGFP were prepared in deionized water (dH 2 O). For in vitro studies, the pGFP plasmid was labeled using YOYO-1 dye (Molecular Probes). For in vivo studies, the pGFP plasmid was labeled using the Mirus Bio Label IT Nucleic Acid Labeling Kit with Cy5 (excitation/emission maximum: 649 nm/670 nm) (see details below).
Liposome and DNA Preparation
Stock solutions of MVL5, cholesterol, and PEG2000-lipid were prepared by dissolving them in a 3:1
(v/v) chloroform/methanol mixture. RGD-, iRGD-, and cRGD-PEG2000-lipid were dissolved in a 65: 25:4 (v/v/v) chloroform/methanol/dH 2 O (dH 2 O, deionized water) mixture. RPARPAR-PEG2000-lipid was dissolved in methanol. Lipid solutions were combined volumetrically at the desired molar ratio, and the solvent was evaporated by a stream of nitrogen followed by incubation in a vacuum overnight (12-16 h). The appropriate amount of high resistivity water (18.2 MΩcm) was added to the dried lipid film to achieve the desired lipid concentration (1 mM). Hydrated films were incubated overnight (12-16 h) at 37 °C to form liposomes. The liposome suspension was then sonicated for 7 minutes using a tip sonicator to promote the formation of small unilamellar vesicles. Plasmid purification was performed according the manufacturers protocol. For in vitro experiments, pGFP was labeled with YOYO-1, using a dye/basepair ratio of 1:30 by incubating the appropriate amounts of dye and pGFP at 37 °C overnight.
For in vivo experiments, pGFP was labeled using Cy5 according to the manufacturer's protocol with one modification: the incubation time at 37 °C was increased from 1 to 2 h to improve labeling efficiency. Characterization of the nanoparticles (size by dynamic light scattering and zeta potential) is described in the Supplementary Material (Tables ST1 and ST2 ).
Membrane Charge Density and Charge Ratio
For the lipid formulations used in this study (10/70/10/10, molar ratio of MVL5/DOPC/Cholesterol/x, with x=PEG-lipid and/or peptide-PEG-lipid), the membrane charge density was low at σ M ≈ 0.0061 e/Å 2 .
The membrane charge density can be calculated from the equation σ M =[1-Φ nl /(Φ nl +rΦ cl )]σ cl [23] . Here, r=A cl /A nl is the ratio of the headgroup areas of the cationic and the neutral lipid; σ cl =eZ/A cl is the charge density of the cationic lipid with valence Z; Φ nl and Φ cl are the molar fractions of the neutral and cationic lipids, respectively. In our nanoparticles, the neutral lipid component is a mixture of DOPC, cholesterol, and the PEG-lipid (with and without peptide). For simplicity, we assigned an estimated average headgroup area (that of DOPC) to this lipid mixture. (Compared to DOPC, cholesterol's headgroup is much smaller, while those of the PEG-lipids are larger.) Thus, the membrane charge density was calculated using A nl =72 Å 2 , r MVL5 =2.3, and Z MVL5 =5.0 [23, 24] . supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin (Invitrogen). Cells were passaged every 72 h to maintain subconfluency and cultured in an incubator at 37 °C in a humidified atmosphere containing 5% CO 2 . MKN-45P human gastric cancer cells were originally isolated from parental MKN-45 cells (a gift from Joji Kitayama) as described [73] . The MKN-45P cells were cultivated in DMEM (Lonza) containing 100 IU/mL of penicillin and streptomycin, and 10% of heatinactivated fetal bovine serum (GE Healthcare).
Cell Culture

Flow Cytometry
Cells were detached using enzyme-free cell dissociation buffer (Gibco), seeded in 24-well plates at a density of 45 000 cells/well, and incubated for 18 h. A total of 1 μg of pGFP (10% YOYO-1-labeled)
was used for each sample (i.e., two wells). This DNA was diluted to 250 μL with DMEM. The appropriate volume of liposomes (to reach the desired lipid/DNA charge ratio) was also diluted to 250 
In vivo biodistribution studies
Athymic nude mice were purchased from Harlan Sprague Dawley. All the animal experimentation protocols were approved by Estonian Ministry of Agriculture, Committee of Animal Experimentation (Project #42). Mice were injected intraperitoneally (IP) with 2ൈ10 6 MKN-45P cells, and the MKN-45P tumors were allowed to grow for two weeks. CL-NA NPs containing Cy5-labeled pGFP were injected IP (0.1 mL of 5 mg/mL solution was diluted in 0.5 mL of PBS). In vivo imaging was performed 4 h and 24 h after injection (See Figure S2 in the Supplementary Material). After 24 h, the animals were perfused with 10 mL of PBS. The tumors and organs were excised for fluorescence visualization using an Optix MX3 (Advanced Research Technologies). Fluorescence quantification was done using the OptiView analysis software. The average fluorescent signal (n=3) was normalized by dividing by the control mouse fluorescence (receiving no injection) and the total grams of tissue. Tumor nodules were separated from membranous tissue connecting the nodules and pooled (for each set of NPs; n=3).
Tissues were snap-frozen in liquid nitrogen and stored at -80°C for further analysis.
Immunofluorescence and microscopic imaging
The snap-frozen tumors and organs were cryosectioned at a thickness of 10 μm and fixed with 4% of paraformaldehyde in PBS. The nuclei of cells were counterstained with 1 μg/ml DAPI. Tissue sections were imaged on a Zeiss LSM 510 (for lower magnification images) and an Olympus FV1200MPE (for higher magnification images), and the confocal images were analyzed with the ZEN lite 2012 and Olympus FluoView image software, respectively.
Results and Discussion
The objective of this work was to investigate how changes in composition, which alter physicochemical parameters (i.e., charge, binding affinity), affect the efficiency and selectivity of peptide-mediated targeting of CL-DNA NPs. We have previously shown that high membrane charge density increases NP uptake but does so via nonspecific, electrostatic interactions. 
In vitro Binding and Internalization of Peptide-Tagged NPs
To assess the effect of peptide density, we fixed the lipid/DNA charge ratio (ρ ch ) at 1.5, which yields near-neutral CL-DNA NPs without added peptide-PEG-lipid in deionized water [17] . The goal behind this was to maximize the contribution of specific interactions to binding and internalization by minimizing nonspecific electrostatic interactions. We varied the peptide density by replacing some or all of the (peptide-less) PEG-lipid with peptide-PEG-lipids (1, 2.5, 5, and 10 mol%). Thus, peptide-PEG-lipids made up 1 to 10 mol% of the lipid mixture, with the combined peptide-PEG-lipid and PEG-lipid content fixed at 10 mol%. At 10 mol% PEG2000-lipid, membranes are coated with PEG in the brush conformation; at contents beyond 10 mol%, PEG2000-lipid phase separates. After incubating PC-3 and M-21 human cancer cells with CL-DNA NPs loaded with fluorescently labeled plasmid DNA for 5 h, we used flow cytometry as a high-throughput method for analyzing NP binding and internalization. Importantly, we measured the cell-associated fluorescence not only after washing of the cells with buffer, but also (separately) after treating the cells with Trypan Blue (TB), a cell-impermeable dye that quenches extracellular fluorescence. The first measurement, typically the only one reported in the literature, yields a combined value for binding and internalization because washing does not remove tightly bound CL-DNA NPs from the surface of cells [31] . The measurement after TB treatment, in contrast, quantifies only fluorescence from internalized nanoparticles [38, 76] . Figure 2B .
A first notable feature of the data shown in Figure 2B is that the difference between the values for combined binding and internalization (green bars) and internalization only (blue bars) varies widely, with those for internalization much lower than those for combined binding and internalization in many cases. This highlights the importance of discriminating between these two values of cell-associated fluorescence. The extent to which combined binding and internalization differs from internalization differs between the cell lines; generally, internalization is much higher relative to combined binding and internalization in M-21 cells than in PC-3 cells. Such differences between cell lines shed light on the fundamental reasons behind the well-established observation that transfection efficiency varies greatly between cell lines.
Another intriguing result in this context is that variation in peptide coverage influences the extent to which combined binding and internalization differs from internalization only. This is true for both cell lines, but is most evident in the PC-3 cells. For these, internalization is highest at the lowest peptide coverage (1% peptide-PEG-lipid content), even though combined binding and internalization is much higher at 2.5 and 5% peptide-PEG-lipid content.
The density of the targeting peptide also affects NP binding and internalization. In broad terms, the total binding and internalization of peptide-tagged NPs increased from 1 to 2.5 mol% peptide, then slowly dropped off for 5 and 10 mol% peptide in PC-3 cells. For M-21 cells, the total binding and internalization increased from 1 up to 5 mol% peptide to drop at 10 mol% peptide. Thus, the optimum peptide coverage depends on the cell line and, to a lesser extent, on the peptide. In particular, and surprisingly, the nanoparticles with highest coverage (10 mol% peptide-PEG-lipid) showed both the lowest combined binding and internalization as well as the lowest internalization (with the sole exception of iRGD-tagged NPs in PC-3 cells). A possible explanation is that the maximum peptide coverage reduced specific peptide-receptor binding due to lateral steric hindrance, because the addition of peptides to the end of all PEG chains results in a thicker hydrophilic corona with a dense peptide region at the surface of the NP. Supporting this idea is the fact that several peptide-targeted NPs at maximum coverage exhibited lower binding and internalization than the control (PEG-lipid only)
NPs.
Focusing in more detail on the effects of surface functionalization, the data in Figure 2 shows that the control NPs (PEG-lipid only; no peptide), unlike naked DNA, exhibited binding and internalization well above the control of untreated cells (which is subtracted from the data shown in Fig. 2 ). However, PEG-lipid only NPs showed lower binding and internalization than the targeted, peptide-tagged NPs, with the already mentioned exception of some NPs at full peptide-coverage (10 mol%). When cells were incubated with cRGD-tagged NPs (at >1 mol% cRGD-PEG-lipid), a large number of them detached from the cell culture substrate (in the case of 5 mol% cRGD-PEG-lipid content on PC-3 cells, this even occurred to the extent that too few cells remained attached to perform the flow cytometry measurement). When we isolated the detached cells, they exhibited extremely high combined binding and internalization ("cRGD (det.)" in Fig. 2 ). However, their fluorescence after Trypan Blue treatment was not higher than that of the cells that stayed attached, suggesting that there may be an upper limit for uptake mediated by binding to α v β 3 integrins. The cells that remained attached showed much lower combined binding and internalization of NPs than the detached cells, with combined binding and internalization at a level comparable to NPs tagged with the other peptides. However, the fraction of internalization was generally higher than that for NPs tagged with other peptides. As to the cause of the detachment, it seems plausible that the cyclic RGD peptides (some detachment of cells was also observed for iRGD-tagged NPs), bind strongly enough to the cell's integrins (cRGD is optimized for binding to α v β 3 integrins) to displace the native ligand fibronectin to an extent that causes the cells to disconnect from the wells. (Fibronectin is used to coat the cell culture substrate's surface to provide attachment points for the cells.)
Binding and internalization of RPARPAR-targeted NPs peaked at 2.5 mol% for PC-3 and 5 mol% for M-21, with the peak binding to PC-3 being ≈ 30% higher in magnitude. Given that the M-21 cells lack the NRP-1 receptor, lower binding and internalization in these cells is expected. Nonetheless, the difference in between the two cell lines is much less pronounced than in prior work that used metal and metal oxide NPs [48] . To understand this result, it is important to consider the net charge of the peptide ligands. While the linear (GRGDSP) and cyclic (cRGD and iRGD) RGD peptides bear no charge or a single negative charge at physiological pH, respectively, the RPARPAR peptide bears two positive charges (see Supplementary Table 1 ). Because the interactions of CL-DNA NPs with cells are very sensitive to charge, the addition of the cationic RPARPAR peptides to the NP surface resulted in high, nonspecific binding and internalization interactions driven by electrostatic interactions. This reasoning is supported by measurements of the zeta potential of our CL-DNA NPs (see Supplementary Table 1A and 1B), which is higher for RPARPAR-tagged NPs than for other NPs (at the same membrane charge density and ρ ch ). To further investigate the interplay between nonspecific (charge-mediated) and specific (peptidemediated) interactions of peptide-tagged NPs with cells, we assessed binding and internalization as a function of the lipid/DNA charge ratio. For this investigation, we chose NPs with a fixed intermediate peptide density (2.5 mol% peptide-PEG-lipid content) that yielded efficient binding and internalization in both investigated cell lines according to the data shown in Figure 2 . The lipid/DNA charge ratio, ρ ch , is the molar ratio of positive charges (on the lipid) to negative charges (on the DNA) in the liposome and DNA solutions that are mixed to form CL-DNA NPs. This ratio is a key parameter governing the transfection efficiency of CL-DNA complexes [23, 77] . We prepared NPs at ρ ch =0.5, 1.0, 1.2, 1.5, and 5.
The isoelectric point (neutral surface charge) of MVL5-based CL-NA complexes has been previously found to be at a ρ ch around 1.5 in high-resistivity, deionized water, which was confirmed by measurements with these NPs (see Supplementary Table 1 ) [17] . Thus, the surface charge of the studied NPs was expected to vary from anionic (ρ ch =0.5) to highly cationic (ρ ch =5). However, it also indicates that low ρ ch , i.e., negative NP charge, abolishes specific, peptide-mediated binding and internalization, suggesting that electrostatic (in this case repulsive) interactions can overpower receptor-mediated interactions.
In general, the effect of ρ ch on binding and internalization of NPs appears to be more pronounced for M-21 cells than for PC-3 cells. This is evident from the steeper slope in the data, in particular for internalization only (Fig. 3 B,D; note the different scales of the y-axes). The data also shows (as observed earlier, see discussion of Figure 2 ) that the internalized NPs constitute a larger fraction of the combined bound and internalized NPs for M-21 cells, again shedding light on the differences between cell lines.
For both cell lines and all charge ratios, the control NPs without peptide ligand (PEG-lipid only;
yellow) showed the lowest values for combined binding and internalization as well as internalization only. However, these control NPs also showed increased binding and internalization with increased ρ ch .
As a consequence, nontargeted, control NPs at ρ ch =5 (highly cationic) had higher binding and internalization than targeted, peptide-tagged NPs at ρ ch =1.5 (near neutral). This shows how powerful a driving force for binding and internalization the NP charge can be, even for PEGylated NPs. Because the control NPs lack specific interactions, the fact that their internalization increases with ρ ch demonstrates that the size of their PEG corona (PEG molecular weight: 2000 g/mol) is insufficient to completely shield electrostatic interactions, even at the low membrane charge density chosen for this investigation. Furthermore, we can use the binding and internalization of the control NPs as a rough measure of the degree of nonspecific binding and internalization. The data in Figure 3 therefore shows that it is important to limit the lipid/DNA charge ratio to minimize interactions of CL-DNA NPs with offtarget tissues (i.e., healthy organs) in vivo.
The measured values for internalization ( Fig. 3 B,D) largely parallel those for combined binding and internalization, with a few notable exceptions. These exceptions once again highlight the value of using an assay that can distinguish the fraction of internalized nanoparticles.
The cells that detached after treatment with cRGD-functionalized NPs (dashed lines in Fig 3A inset and Fig. 3C ) are one exception. When these cells could be analyzed (at intermediate ρ ch ), combined binding and internalization was again extremely high, but internalization was similar to that seen in the cells that stayed attached and exhibited much lower combined binding and internalization. One possible explanation for this behavior is that there is a maximum level of uptake that can be mediated by the binding of cRGD to its α v β 3 integrin receptor. An alternative explanation is that detachment from the substrate may have halted internalization of the NPs by the cells; it is known that significant physiological changes occur when cells are detached from their surrounding matrix, including cell death [78] .
The M-21 cells that remained attached after incubation with cRGD-tagged NPs are another exception. In contrast to the detached cells, these cells showed very high internalization of NPs relative to total binding and internalization. In some cases, the normalized fluorescence after incubation with Trypan Blue even was higher than without this treatment, an unexpected behavior which is the subject of ongoing investigations.
The final exception are NPs functionalized with the RPARPAR peptide. These NPs showed some of the highest combined binding and internalization in both cell lines (for attached cells). While this corresponded to high internalization values for PC-3 cells, internalization was much lower for M-21 cells (as low as that of PEGylated control NPs at ρ ch =5, where combined binding and internalization is highest). Since M-21 cells lack the NRP-1 receptor, a likely explanation for this large difference between the cell lines is that the combined binding and internalization is dominated by charge-mediated electrostatic interactions of NPs and cells while much of the uptake is dominated by receptor-mediated interactions. In other words, the charge of the NPs (which is increased over that of the control NPs by Based on the result for the M-21 cells, we may take the difference between internalization of RPARPAR-tagged and control NPs in PC-3 cells as an estimate of the specific, receptor-mediated uptake. Interestingly, this difference also increases with ρ ch . This finding (supported by the fact that the internalization of all NPs increases with ρ ch ) highlights the interplay between charge-and receptormediated uptake. It suggests that, for optimum uptake, the charge ratio of the NPs should be as large as possible without causing excessive off-target binding and internalization (after the charge of the peptide is taken into consideration).
Regarding the effect of other peptides, the peptide mediating the highest combined binding and internalization by both PC-3 and M-21 cells again is cRGD (in detached cells). Even in the cells that did not detach from the substrate, cRGD-tagged NPs were consistently among those with the highest binding and internalization. While NPs tagged with cRGD and RPARPAR often showed the highest binding and internalization, NPs conjugated to iRGD or GRGDSP peptides consistently had increased levels of binding and internalization above the control NPs (especially the combined binding and internalization in PC-3 cells which is quite high for linear RGD). In our in vitro experiments, the cryptic CendR motif of the iRGD peptide is not exposed [60] . Thus, the presence or absence of the NRP-1 receptor (in PC-3 and M-21 cells) is not expected to play a role in binding or internalization of NPs tagged with iRGD. This could explain why the binding and internalization of the iRGD peptide in PC-3 cells was low. 
In vivo Biodistribution
Having established guidelines for selecting compositional parameters by our in vitro experime we sought to validate our approach with in vivo studies. To this end, we performed biodistribu [69] . Clinically, after surgical resection of the primary tumors (cytoreduction), microscopic tumor nodules and disseminated cancer cells that remain in the peritoneal cavity may grow into new tumors, resulting in cancer recurrence [69, [79] [80] [81] . To eliminate the cancer cells remaining after surgery, locoregional intraperitoneal (IP) chemotherapy is increasingly used to achieve elevated drug concentration in the IP space and to decrease systemic exposure [69, 81, 82] .
Despite these advances, 60% of PC patients still experience cancer recurrence [83] .
Based on the findings of the in vitro studies, we chose low membrane charge density (10 mol% MVL5), a moderate charge ratio (ρ ch =1.5), and intermediate peptide ligand density (5 mol%) as compositional parameters expected to yield maximal, but specific, binding. PEGylated (no peptide) NPs at this composition served as the NP control. As peptide ligands, we chose cRGD in view of the extremely high binding it mediated in vitro, as well as iRGD because of its unique ability to penetrate into tumors [60] , which is a property that is hard to assess in vitro. While the internalization of cRGDtagged NPs in vitro did not stand out as much as their binding, binding to cells is the required first step for internalization. Therefore, maximizing it seemed a prudent strategy. On the other hand, the lower affinity of the linear GRGDSP peptide and concerns about reduced specificity caused by the charge of the RPARPAR peptide prompted us to not take these peptides into in vivo experiments.
Mice bearing IP MKN-45P tumors were intraperitoneally injected with the three different NP compositions (n=3). Whole animal in vivo imaging was performed 4 h and 24 h after the fluorescent NPs were administered (see Figure S2 in the Supplementary Material). At 24 h, the mice were sacrificed, and the tumors and control organs were excised and analyzed by macroscopic fluorescence imaging ( Figure 3 ) and confocal imaging of tissue sections (Figure 4 ). For all NP formulations, the observed fluorescence was much higher in the tumor than in any other organs. Outside of the tumor, the highest fluorescence per gram of tissue was seen in the liver and lung. The confocal imaging of tissue sections confirmed the low accumulation of NPs in healthy tissues (see Figure S3 in the Supplementary Material).
The combined data shows that the intraperitoneally injected NPs efficiently home to tumors. Both whole organ fluorescence and confocal imaging of tissue sections indicate that NP accumulation in the tumor was significantly higher than off-target, liver accumulation for nontargeted PEG NPs and, to a greater extent, for the targeted iRGD-and cRGD-tagged NPs. The low but detectable presence of peptide-tagged NPs in the lungs and the liver indicates that some NPs have escaped the abdominal cavity after IP injection and entered the bloodstream. However, accumulation in the liver was much lower than is typical for nanometer-size particles. The control NPs showed a preference for binding tumor tissue despite the lack of specific peptide-ligand binding. This suggests that some tumor homing results from remaining nonspecific effects (e.g., charge or size). The iRGD-and cRGD-tagged NP formulations showed even higher accumulation in the tumor tissue, providing evidence of the benefi effect of specific receptor-ligand binding for tumor homing. 
In vivo Tumor Penetration
To examine the distribution of the NPs in the tumor tissue we used fluorescence confo microscopy. After the tumor nodules were dissected free from the membranous tissue connecting th the nodules from mice that received identical NPs (n=3) were pooled, snap-frozen, cryosectioned, imaged. Representative images are shown in Figure 5 . All NP formulations showed some NP bindin the surface of the tumor nodules and superficial (10-20 μm) penetration. Interestingly, the iRGD-cRGD-targeted NPs had a tendency to accumulate in small tumor nodules (diameter≈300 μm). T peptide-tagged NPs penetrated deeper (>100 μm) into these small tumor nodules, as evident in Fig   5D and 5F. The preference for small tumor nodules is likely related to receptor-ligand binding beca tumor penetration is observed for both peptide-tagged NPs but not for the control NPs. A poss explanation for this preference is that there is a difference in integrin expression between small large tumor nodules. Regardless of the mechanism behind it, the preference of the peptide-tagged N 
Conclusion
Effective tissue targeting by CL-NA NPs requires both strong specific, peptide-mediated binding and minimal nonspecific, charge-mediated binding between the cationic membranes of the NP vector and anionic sulfated surface proteoglycans. We have demonstrated the interplay between chargemediated and peptide-mediated binding in this study of a variety of compositional parameters.
Nonspecific binding and internalization of CL-NA NPs is primarily governed by the NP's surface charge. The surface charge is strongly affected by the cationic lipid to nucleic acid charge ratio and the cationic membrane charge density. To minimize nonspecific interactions, membrane charge density must be low and the lipid/DNA charge ratio near 1 (ideally on the cationic side of the isoelectric point, as noted in the discussion of Figure 3 ). However, our data clearly shows that the charge of the peptide ligand must also be taken into account. As seen in the case of the RPARPAR peptide, charge-mediated interactions caused by the peptide can obscure specific interactions. This is the case particularly if cellular internalization is not distinguished from the combined binding and internalization that is usually measured. Thanks to the modular nature of CL-NA vectors, a positive charge on the peptide can be offset by reducing ρ ch .
Binding and internalization of CL-DNA NPs also varies significantly with the density of peptide ligands. Notably and somewhat counterintuitively, we found that maximum peptide coverage resulted in inferior binding and internalization compared to intermediate coverage. While the optimum peptide coverage depends on the cell line, our results suggest that the optimum ligand density is largely independent of the targeting peptide for a given cell line. We found that generally 2.5 mol% and 5 mol% were the optimal peptide-PEG-lipid densities for PC-3 cells and M-21 cells, respectively. (All formulations contained a mixture of PEG-lipid and peptide-PEG-lipid with a combined concentration of 10 mol% of total lipid.)
The effective targeting of liposomal carriers to specific tissues in vivo is critical for the future of synthetic NA delivery vectors in medicine. By modulating the charge and targeting properties of peptide-tagged CL-NA NPs, we were able to identify NP formulations in vitro that proved to have very good tumor-homing properties in vivo. This was achieved using integrin-and NRP-1-binding peptides as tumor-targeting ligands, rather than large antibodies. In an in vivo mouse model of human peritoneal carcinomatosis, IP-administered CL-DNA NPs targeted with iRGD or cRGD successfully targeted and penetrated microscopic tumor nodules similar to those most likely to cause cancer recurrence in human patients, while also showing very little accumulation in healthy tissue. This demonstrates the utility of the systematic exploration of CL-NA NP formulation space, especially as it concerns the surface charge of the nanoparticle.
Expression of the delivered DNA was low, but the time scale of our in vivo biodistribution experiments was too short to reliably assess this aspect, and the DNA contained a large amount of covalently attached fluorophore. Future work will focus on therapeutic properties of the targeted CL-DNA NPs and require strategies to improve the expression of the delivered DNA cargo. The modular nature of CL-NA NPs facilitates implementation of such strategies for increasing endosomal escape and delivery of the NA cargo, e.g., by including acid-labile PEG-lipids [84] or ionizable lipids with pHdependent charge that increase the membrane charge density within late endosomes. Such strategies will allow the NPs to maintain low membrane charge density and charge ratio as well as steric shielding stealth during circulation while leading to stronger NP-cell membrane interactions and ultimately fusion in the low-pH environment of the late endosome.
Our study demonstrates the importance of tuning the physicochemical parameters of CL-NA NPs (e.g., charge and ligand properties) to minimize nonspecific, electrostatic binding and maximize specific, peptide-mediated binding for efficient solid tumor targeting. By narrowing down the parameter space that needs to be explored for new formulations using novel peptides or different cargo (e.g. siRNA or proteins), the discovered trends will be useful for future optimization of peptide-targeted nanoparticles.
